SRDFM: Siamese Response Deep Factorization Machine to improve anti-cancer drug recommendation

Ran Su1, YiXuan Huang2, De-Gan Zhang3,4

  • 1The University of New South Wales, Australia.

Insights

We developed a deep learning model called Siamese Response Deep Factorization Machines (SRDFM) Network for personalized anti-cancer drug recommendation. This method ranks drugs to identify the most effective treatments for individual cancer patients, improving personalized oncology.

Area of Science:

  • Oncology
  • Bioinformatics
  • Artificial Intelligence

Background:

  • Personalized cancer treatment requires predicting patient response to therapies.
  • Clinicians need effective drug recommendations rather than precise sensitivity values.
  • Existing methods may not adequately handle complex drug-gene interactions or novel drug properties.

Purpose of the Study:

  • To develop a deep learning-based method for personalized anti-cancer drug recommendation.
  • To directly rank drugs for identifying the most effective treatments for individual cancer patients.
  • To enable drug recommendations even for new drugs with limited known properties.

Main Methods:

  • Proposed the Siamese Response Deep Factorization Machines (SRDFM) Network, a deep learning model.
  • Utilized a Siamese network (SN) to measure the relative position (RP) between drugs for cell lines.
  • Integrated drug properties and gene expression data, incorporating a response unit for weighted genetic features.
  • Combined Factorization Machines (FM) with deep neural networks for predictor construction.

Main Results:

  • The SRDFM network effectively ranks anti-cancer drugs for personalized recommendation.
  • The model demonstrates efficiency in both single-drug and drug combination recommendations.
  • The approach successfully simulates biological interaction mechanisms between drugs and genes.
  • The method accommodates new drugs by utilizing chemical properties.

Conclusions:

  • The SRDFM Network provides a powerful tool for personalized anti-cancer drug recommendation.
  • This deep learning approach enhances the identification of effective cancer treatments.
  • The SRDFM Network shows promise for advancing precision oncology and drug discovery.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K